SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-052965
Filing Date
2024-04-26
Accepted
2024-04-26 16:18:34
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2412691d1_s3.htm S-3 183307
2 EXHIBIT 5.1 tm2412691d1_ex5-1.htm EX-5.1 11370
3 EXHIBIT 23.1 tm2412691d1_ex23-1.htm EX-23.1 1930
4 EX-FILING FEES tm2412691d1_ex-filingfees.htm EX-FILING FEES 16940
5 GRAPHIC tm2412691d1_ex5-1img01.jpg GRAPHIC 2769
6 GRAPHIC tm2412691d1_s3img01.jpg GRAPHIC 8046
  Complete submission text file 0001104659-24-052965.txt   229904
Mailing Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830
Business Address 111 S. WOOD AVENUE UNIT #100 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-278959 | Film No.: 24884052
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)